Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT02799095 ×

NCT02799095

This funder is selected. Its supporting articles are shown below.

NCT027990951

Articles mentioning NCT02799095

1 articles · page 1 of 1

Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial

jitc · abstract · 2025-08-04 · 1 matching annotations

75.4%

NCT02799095 advanced solid tumors pembrolizumab melanoma ARTISTRY-1 renal cell carcinoma nemvaleukin Nemvaleukin alfa RCC

…tients with advanced melanoma and RCC.Trial registration number NCT02799095.…